Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study

Hypertension Research

Volumn 31, Issue 3, 2008, Pages 469-478

  Shimamoto, Kazuaki ^a   Fujita, Toshiro ^b   Ito, Sadayoshi ^c   Naritomi, Hiroaki ^d   Ogihara, Toshio ^e   Shimada, Kazuyuki ^f   Tanaka, Heizo ^g   Yoshiike, Nobuo ^h  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g KOSHIEN UNIVERSITY   (Japan)

^h NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Blood pressure; Cardiovascular disease; Hypertension; Losartan; Observational study

Indexed keywords

LOSARTAN;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK REDUCTION; STROKE; SUBARACHNOID HEMORRHAGE; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; LOSARTAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE;

EID: 42649092612     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.469     Document Type: Article

References (31)

1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
2. Dahlof B, Devereux RB, Kjeldsen SE, et al: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
3. Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists' Collaboration: Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955-1964.
4. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315.
5. Japanese Society of Hypertension: Guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29 (Suppl): S1-S105.
6. Chobanian AV, Bakris GL, Black HR, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
7. Naritomi H, Fujita T, Ito S, et al: Design and baseline characteristics of a cohort study in Japanese patients with hypertension: Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH). Hypertens Res 2007; 30: 807-814.
8. Naritomi H, Fujita T, Ito S, et al: Efficacy and safety of long-term losartan therapy demonstrated by a cohort study in Japanese patients with hypertension: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) Study. Hypertens Res 2008; 31: 295-304.
9. Black HR, Elliott WJ, Grandits G, et al: Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289: 2073-2082.
10. Tanizaki Y, Kiyohara Y, Kato I, et al: Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000; 31: 2616-2622.
11. Matsuzaki M, Kita T, Mabuchi H, et al: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: 1087-1095.
12. Ueda K, Omae T, Hasuo Y, et al: Prognosis and outcome of elderly hypertensives in a Japanese community: results from a long-term prospective study. J Hypertens 1988; 6: 991-997.
13. Hansson L, Zanchetti A, Carruthers SG, et al, HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755-1762.
14. Shimamoto K, Kita T, Mabuchi H, et al: Effects of hypertension and type 2 diabetes mellitus on the risk of total cardiovascular events in Japanese patients with hypercholesterolemia: Implications from the Japan Lipid Intervention Trial (J-LIT). Hypertens Res 2007; 30: 119-123.
15. American Diabetes Association: Treatment of hypertension in adults with diabetes. Diabetes Care 2002; 25: 199-201.
16. Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
17. Lewington S, Clarke R, Qizilbash N, Pete R, Collins R, Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
18. Goldstein LB, Adams R, Becker K, et al: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001; 103: 163-182.
19. Ferrucci L, Furberg CD, Penninx BWJH, et al: Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile. Circulation 2001; 104: 1923-1926.
20. Amery A, Birkenhäger W, Brixko P, et al: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; 1 (8442): 1349-1354.
21. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
22. Heikinheimo RJ, Haavisto MV, Kaarela RH, Kanto AJ, Koivunen MJ, Rajala SA: Blood pressure in the very old. J Hypertens 1990; 8: 361-367.
23. Kjeldsen SE, Dahlof B, Devereux RB, et al: Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention For Endpoint Reduction (LIFE) substudy. JAMA 2002; 288: 1491-1498.
24. August P: Initial treatment of hypertension. N Engl J Med 2003; 348: 610-617.
25. Arima H, Tanizaki Y, Kiyohara Y, et al: Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study. Arch Intern Med 2003; 163: 361-366.
26. Perry HM Jr, Davis BR, Price TR, et al: Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA 2000; 284: 465-471.
27. Bulpitt C, Fletcher A, Beckett N, et al: Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging 2001; 18: 151-164.
28. Bulpitt CJ, Beckett NS, Cooke J, et al: Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003; 21: 2409-2417.
29. JATOS Study Group: The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months. Hypertens Res 2005; 28: 513-520.
30. Ogihara T, Saruta T, Matsuoka H, et al: Valsartan in Elderly Isolated Systolic Hypertension (VALISH) study: rationale and design. Hypertens Res 2004; 27: 657-661.
31. Boutitie F, Gueyffier F, Pocock S, Fagard R, Boissel JP, The INDANA Project Steering Committee: J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002; 136: 438-448.